Description
December 12, 2025
Cervical Cancer Screening Guidelines from the American Cancer Society
Clinical Laboratory Science Investigator Award, CAP Foundation
Hosted on Ausha. See ausha.co/privacy-policy for more information.
Transcription
- Nancy Johnson
New guidelines for detecting cervical cancer and an opportunity for pathology residents to get hands-on clinical lab training. These stories and more coming up. This is Path News Network Daily Edition from the College of American Pathologists. I'm Nancy Johnson. It's Friday, December 12th. The American Cancer Society has released updated guidelines urging women and anyone with a cervix to begin cervical cancer screening at age 25 and continue through at least age 65. Almost all cervical cancers stem from long-lasting HPV infections. As a result, the organization now recommends primary HPV testing every five years. Experts say regular screening can catch precancerous changes early, allowing treatment before cancer develops. A leading bladder cancer specialist says progression in low-grade, non-muscle invasive bladder cancer is uncommon, but it's still important to watch carefully. Dr. Roger L is an oncologist at Moffitt Cancer Center in Tampa. He notes that fewer than 5% of patients progress to muscle invasive or metastatic disease, but as many as 10% to 20% of those patients may advance to high-grade cancer. New AI pathology tools could help clarify the risk by detecting subtle features in standard pathology slides that humans may miss. Dr. Li says if validated, the technology could guide more personalized monitoring and treatment for patients. The global market for anatomic pathology tools is booming as demand grows for faster, more accurate disease diagnosis. According to market research from S&S Insider, the industry is expected to nearly double from about $38 billion in 2023 to more than $74 billion by 2032. Experts say rising rates of chronic illnesses like cancer are driving the need for better testing. New tools such as digital pathology and artificial intelligence are also speeding up lab work and improving accuracy. And finally, if you're a pathology resident, you have a chance to train at Eli Lilly's Clinical Diagnostics Laboratory. The CAP Foundation is offering the Clinical Laboratory Science Investigator Award. The four-week program gives participants hands-on experience with biomarker research, clinical trial workflows. and advanced analytical techniques. Recipients can receive up to $5,000 to help cover travel and living expenses during the training. The application deadline is December 19th. That's all for today. Be sure to check the show notes for more information on today's stories. Watch your email inbox for more news like this in the CAP's Advocacy Newsletter every Tuesday and our Weekly Edition Newsletter on Thursdays. We're back Monday at 5 a.m. Eastern for another episode of The Daily Edition. I'm Nancy Johnson. Have a great day.
Description
December 12, 2025
Cervical Cancer Screening Guidelines from the American Cancer Society
Clinical Laboratory Science Investigator Award, CAP Foundation
Hosted on Ausha. See ausha.co/privacy-policy for more information.
Transcription
- Nancy Johnson
New guidelines for detecting cervical cancer and an opportunity for pathology residents to get hands-on clinical lab training. These stories and more coming up. This is Path News Network Daily Edition from the College of American Pathologists. I'm Nancy Johnson. It's Friday, December 12th. The American Cancer Society has released updated guidelines urging women and anyone with a cervix to begin cervical cancer screening at age 25 and continue through at least age 65. Almost all cervical cancers stem from long-lasting HPV infections. As a result, the organization now recommends primary HPV testing every five years. Experts say regular screening can catch precancerous changes early, allowing treatment before cancer develops. A leading bladder cancer specialist says progression in low-grade, non-muscle invasive bladder cancer is uncommon, but it's still important to watch carefully. Dr. Roger L is an oncologist at Moffitt Cancer Center in Tampa. He notes that fewer than 5% of patients progress to muscle invasive or metastatic disease, but as many as 10% to 20% of those patients may advance to high-grade cancer. New AI pathology tools could help clarify the risk by detecting subtle features in standard pathology slides that humans may miss. Dr. Li says if validated, the technology could guide more personalized monitoring and treatment for patients. The global market for anatomic pathology tools is booming as demand grows for faster, more accurate disease diagnosis. According to market research from S&S Insider, the industry is expected to nearly double from about $38 billion in 2023 to more than $74 billion by 2032. Experts say rising rates of chronic illnesses like cancer are driving the need for better testing. New tools such as digital pathology and artificial intelligence are also speeding up lab work and improving accuracy. And finally, if you're a pathology resident, you have a chance to train at Eli Lilly's Clinical Diagnostics Laboratory. The CAP Foundation is offering the Clinical Laboratory Science Investigator Award. The four-week program gives participants hands-on experience with biomarker research, clinical trial workflows. and advanced analytical techniques. Recipients can receive up to $5,000 to help cover travel and living expenses during the training. The application deadline is December 19th. That's all for today. Be sure to check the show notes for more information on today's stories. Watch your email inbox for more news like this in the CAP's Advocacy Newsletter every Tuesday and our Weekly Edition Newsletter on Thursdays. We're back Monday at 5 a.m. Eastern for another episode of The Daily Edition. I'm Nancy Johnson. Have a great day.
Share
Embed
You may also like
